Debate over details of US biosimilar pathway continues to rage

Overview of attention for article published in Nature Biotechnology, July 2012

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 5 X posts from 4 X users, with an upper bound of 35,146 followers.

RT @jrkelly: Debate over details of US biosimilar pathway continues to rage http://t.co/IGmQiqgT

RT @bermaninstitute: Debate over details of US biosimilar pathway continues to rage http://t.co/0d3aVNUN #Bioethics

Debate over details of US biosimilar pathway continues to rage http://t.co/IGmQiqgT

RT @bermaninstitute: Debate over details of US biosimilar pathway continues to rage http://t.co/0d3aVNUN #Bioethics

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.